Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Laurence Reid currently holds 17,400 shares of KalVista Pharmaceuticals, Inc. (KALV), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Laurence Reid has been a net seller of KALV stock. They have purchased $86.4K and sold $5.2M worth of shares.
Laurence Reid's most recent insider trade was on Jun 9, 2026, when they sold 17,400 shares at $0.00 per share.
Laurence Reid serves as Executive at KalVista Pharmaceuticals, Inc. (KALV). They have executed 38 insider transactions totaling $5.3M over their tenure at the company.
Laurence Reid holds the position of Executive at KalVista Pharmaceuticals, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 15 years and currently hold a stake valued at $0.
Laurence Reid has shown a selling trading pattern, with $86.4K in total purchases and $5.2M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Laurence Reid was on Feb 19, 2014, when they sold $917.4K worth of ALNY shares. This transaction involved 11,465 shares at $80.02 per share.
Laurence Reid currently owns 17,400 shares of KalVista Pharmaceuticals, Inc. (KALV), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Laurence Reid's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Laurence Reid has 38 Form 4 filings on record as an insider at KalVista Pharmaceuticals, Inc..
Set alerts for Laurence Reid and 40,000+ other insiders.